nodes	percent_of_prediction	percent_of_DWPC	metapath
Paricalcitol—Cholecalciferol—ulcerative colitis	0.298	1	CrCtD
Paricalcitol—chronic kidney failure—Cholecalciferol—ulcerative colitis	0.194	1	CpDpCtD
Paricalcitol—VDR—ulcerative colitis	0.151	1	CbGaD
Paricalcitol—VDR—Cholecalciferol—ulcerative colitis	0.0852	0.737	CbGbCtD
Paricalcitol—Calcidiol—Cholecalciferol—ulcerative colitis	0.0333	0.167	CrCrCtD
Paricalcitol—Calcitriol—Cholecalciferol—ulcerative colitis	0.0333	0.167	CrCrCtD
Paricalcitol—Alfacalcidol—Cholecalciferol—ulcerative colitis	0.0333	0.167	CrCrCtD
Paricalcitol—Ergocalciferol—Cholecalciferol—ulcerative colitis	0.0333	0.167	CrCrCtD
Paricalcitol—Calcipotriol—Cholecalciferol—ulcerative colitis	0.0333	0.167	CrCrCtD
Paricalcitol—Dihydrotachysterol—Cholecalciferol—ulcerative colitis	0.0333	0.167	CrCrCtD
Paricalcitol—CYP3A4—Budesonide—ulcerative colitis	0.00779	0.0674	CbGbCtD
Paricalcitol—CYP3A4—Methylprednisolone—ulcerative colitis	0.00348	0.0301	CbGbCtD
Paricalcitol—CYP3A4—Nicotine—ulcerative colitis	0.00339	0.0293	CbGbCtD
Paricalcitol—CYP3A4—Cholecalciferol—ulcerative colitis	0.00304	0.0263	CbGbCtD
Paricalcitol—CYP3A4—Triamcinolone—ulcerative colitis	0.00264	0.0228	CbGbCtD
Paricalcitol—CYP3A4—Betamethasone—ulcerative colitis	0.00226	0.0196	CbGbCtD
Paricalcitol—CYP3A4—Prednisolone—ulcerative colitis	0.00223	0.0193	CbGbCtD
Paricalcitol—CYP3A4—Hydrocortisone—ulcerative colitis	0.00212	0.0183	CbGbCtD
Paricalcitol—CYP3A4—Prednisone—ulcerative colitis	0.00211	0.0182	CbGbCtD
Paricalcitol—CYP3A4—Dexamethasone—ulcerative colitis	0.00132	0.0114	CbGbCtD
Paricalcitol—CYP24A1—Vitamin D Metabolism—VDR—ulcerative colitis	0.000424	0.0833	CbGpPWpGaD
Paricalcitol—Dihydrotachysterol—VDR—ulcerative colitis	0.000356	0.209	CrCbGaD
Paricalcitol—VDR—Nuclear Receptors—NR5A2—ulcerative colitis	0.000351	0.0689	CbGpPWpGaD
Paricalcitol—VDR—Nuclear Receptor transcription pathway—NR5A2—ulcerative colitis	0.000277	0.0545	CbGpPWpGaD
Paricalcitol—UGT1A4—NRF2 pathway—SLC39A11—ulcerative colitis	0.000248	0.0488	CbGpPWpGaD
Paricalcitol—VDR—Drug Induction of Bile Acid Pathway—ABCB1—ulcerative colitis	0.000233	0.0457	CbGpPWpGaD
Paricalcitol—Calcipotriol—VDR—ulcerative colitis	0.000229	0.134	CrCbGaD
Paricalcitol—Alfacalcidol—VDR—ulcerative colitis	0.000229	0.134	CrCbGaD
Paricalcitol—Calcidiol—VDR—ulcerative colitis	0.000229	0.134	CrCbGaD
Paricalcitol—Calcitriol—VDR—ulcerative colitis	0.000204	0.12	CrCbGaD
Paricalcitol—VDR—Nuclear Receptors—HNF4A—ulcerative colitis	0.000196	0.0385	CbGpPWpGaD
Paricalcitol—Calcipotriol—MPO—ulcerative colitis	0.000171	0.1	CrCbGaD
Paricalcitol—Ergocalciferol—VDR—ulcerative colitis	0.000163	0.0958	CrCbGaD
Paricalcitol—CYP24A1—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—ulcerative colitis	0.000159	0.0313	CbGpPWpGaD
Paricalcitol—CYP24A1—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—ulcerative colitis	0.000159	0.0313	CbGpPWpGaD
Paricalcitol—VDR—Nuclear Receptor transcription pathway—HNF4A—ulcerative colitis	0.000155	0.0304	CbGpPWpGaD
Paricalcitol—UGT1A4—Constitutive Androstane Receptor Pathway—ABCB1—ulcerative colitis	0.000134	0.0263	CbGpPWpGaD
Paricalcitol—VDR—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—ulcerative colitis	0.000134	0.0263	CbGpPWpGaD
Paricalcitol—UGT1A4—Aryl Hydrocarbon Receptor Pathway—IL12B—ulcerative colitis	0.000133	0.0261	CbGpPWpGaD
Paricalcitol—VDR—Regulation of nuclear SMAD2/3 signaling—RUNX3—ulcerative colitis	0.000131	0.0258	CbGpPWpGaD
Paricalcitol—Cholecalciferol—VDR—ulcerative colitis	0.000124	0.0726	CrCbGaD
Paricalcitol—VDR—Direct p53 effectors—PRDM1—ulcerative colitis	0.00012	0.0236	CbGpPWpGaD
Paricalcitol—CYP24A1—Phase 1 - Functionalization of compounds—PTGS1—ulcerative colitis	0.000117	0.023	CbGpPWpGaD
Paricalcitol—VDR—RXR and RAR heterodimerization with other nuclear receptor—PPARG—ulcerative colitis	0.000115	0.0226	CbGpPWpGaD
Paricalcitol—CYP24A1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—ulcerative colitis	0.000111	0.0218	CbGpPWpGaD
Paricalcitol—VDR—Regulation of nuclear SMAD2/3 signaling—HNF4A—ulcerative colitis	0.000107	0.021	CbGpPWpGaD
Paricalcitol—VDR—Generic Transcription Pathway—ZFP90—ulcerative colitis	0.000104	0.0205	CbGpPWpGaD
Paricalcitol—VDR—Direct p53 effectors—COL18A1—ulcerative colitis	9.64e-05	0.019	CbGpPWpGaD
Paricalcitol—VDR—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—ulcerative colitis	9.3e-05	0.0183	CbGpPWpGaD
Paricalcitol—VDR—Nuclear Receptors—PPARG—ulcerative colitis	8.51e-05	0.0167	CbGpPWpGaD
Paricalcitol—VDR—Direct p53 effectors—IRF5—ulcerative colitis	7.43e-05	0.0146	CbGpPWpGaD
Paricalcitol—VDR—Nuclear Receptor transcription pathway—PPARG—ulcerative colitis	6.72e-05	0.0132	CbGpPWpGaD
Paricalcitol—CYP3A4—Codeine and Morphine Metabolism—ABCB1—ulcerative colitis	6.59e-05	0.0129	CbGpPWpGaD
Paricalcitol—VDR—RXR and RAR heterodimerization with other nuclear receptor—TGFB1—ulcerative colitis	6.55e-05	0.0129	CbGpPWpGaD
Paricalcitol—VDR—Regulation of nuclear SMAD2/3 signaling—IL10—ulcerative colitis	6.48e-05	0.0127	CbGpPWpGaD
Paricalcitol—CYP24A1—Biological oxidations—PTGS1—ulcerative colitis	6.23e-05	0.0122	CbGpPWpGaD
Paricalcitol—VDR—RXR and RAR heterodimerization with other nuclear receptor—TNF—ulcerative colitis	6.12e-05	0.012	CbGpPWpGaD
Paricalcitol—UGT1A4—Aryl Hydrocarbon Receptor Pathway—IFNG—ulcerative colitis	5.72e-05	0.0112	CbGpPWpGaD
Paricalcitol—UGT1A4—Aryl Hydrocarbon Receptor Pathway—IL1B—ulcerative colitis	5.1e-05	0.01	CbGpPWpGaD
Paricalcitol—UGT1A4—Aryl Hydrocarbon Receptor Pathway—IL2—ulcerative colitis	5.08e-05	0.00998	CbGpPWpGaD
Paricalcitol—VDR—Gene Expression—ZFP90—ulcerative colitis	5.02e-05	0.00986	CbGpPWpGaD
Paricalcitol—UGT1A4—Biological oxidations—PTGS1—ulcerative colitis	4.98e-05	0.00978	CbGpPWpGaD
Paricalcitol—VDR—Generic Transcription Pathway—NR5A2—ulcerative colitis	4.79e-05	0.00941	CbGpPWpGaD
Paricalcitol—UGT1A4—Aryl Hydrocarbon Receptor Pathway—TGFB1—ulcerative colitis	3.96e-05	0.00778	CbGpPWpGaD
Paricalcitol—UGT1A4—Aryl Hydrocarbon Receptor Pathway—TNF—ulcerative colitis	3.7e-05	0.00727	CbGpPWpGaD
Paricalcitol—CYP3A4—Drug Induction of Bile Acid Pathway—ABCB1—ulcerative colitis	3.6e-05	0.00708	CbGpPWpGaD
Paricalcitol—CYP3A4—Drug Induction of Bile Acid Pathway—VDR—ulcerative colitis	3.6e-05	0.00707	CbGpPWpGaD
Paricalcitol—VDR—Generic Transcription Pathway—HNF4A—ulcerative colitis	2.67e-05	0.00526	CbGpPWpGaD
Paricalcitol—VDR—Generic Transcription Pathway—MAML2—ulcerative colitis	2.61e-05	0.00512	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—CHP1—ulcerative colitis	2.55e-05	0.00501	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism of lipids and lipoproteins—PTGS1—ulcerative colitis	2.39e-05	0.0047	CbGpPWpGaD
Paricalcitol—Oedema—Prednisolone—ulcerative colitis	2.36e-05	0.000674	CcSEcCtD
Paricalcitol—Dizziness—Azathioprine—ulcerative colitis	2.36e-05	0.000672	CcSEcCtD
Paricalcitol—Loss of consciousness—Triamcinolone—ulcerative colitis	2.34e-05	0.000668	CcSEcCtD
Paricalcitol—Loss of consciousness—Methylprednisolone—ulcerative colitis	2.33e-05	0.000666	CcSEcCtD
Paricalcitol—Asthenia—Mesalazine—ulcerative colitis	2.33e-05	0.000664	CcSEcCtD
Paricalcitol—Shock—Prednisolone—ulcerative colitis	2.32e-05	0.000663	CcSEcCtD
Paricalcitol—Cough—Triamcinolone—ulcerative colitis	2.32e-05	0.000663	CcSEcCtD
Paricalcitol—Oedema—Hydrocortisone—ulcerative colitis	2.31e-05	0.000658	CcSEcCtD
Paricalcitol—VDR—Gene Expression—NR5A2—ulcerative colitis	2.3e-05	0.00453	CbGpPWpGaD
Paricalcitol—Hypertension—Triamcinolone—ulcerative colitis	2.3e-05	0.000656	CcSEcCtD
Paricalcitol—Pruritus—Mesalazine—ulcerative colitis	2.3e-05	0.000655	CcSEcCtD
Paricalcitol—Hypertension—Methylprednisolone—ulcerative colitis	2.29e-05	0.000654	CcSEcCtD
Paricalcitol—Infection—Hydrocortisone—ulcerative colitis	2.29e-05	0.000654	CcSEcCtD
Paricalcitol—Hyperhidrosis—Prednisolone—ulcerative colitis	2.28e-05	0.000652	CcSEcCtD
Paricalcitol—Shock—Hydrocortisone—ulcerative colitis	2.27e-05	0.000648	CcSEcCtD
Paricalcitol—Myalgia—Triamcinolone—ulcerative colitis	2.27e-05	0.000647	CcSEcCtD
Paricalcitol—Vomiting—Azathioprine—ulcerative colitis	2.27e-05	0.000646	CcSEcCtD
Paricalcitol—Nervous system disorder—Hydrocortisone—ulcerative colitis	2.26e-05	0.000646	CcSEcCtD
Paricalcitol—Arthralgia—Methylprednisolone—ulcerative colitis	2.26e-05	0.000645	CcSEcCtD
Paricalcitol—Myalgia—Methylprednisolone—ulcerative colitis	2.26e-05	0.000645	CcSEcCtD
Paricalcitol—Eye disorder—Prednisone—ulcerative colitis	2.26e-05	0.000644	CcSEcCtD
Paricalcitol—Anxiety—Methylprednisolone—ulcerative colitis	2.25e-05	0.000643	CcSEcCtD
Paricalcitol—Rash—Azathioprine—ulcerative colitis	2.25e-05	0.000641	CcSEcCtD
Paricalcitol—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—ulcerative colitis	2.25e-05	0.000641	CcSEcCtD
Paricalcitol—Dermatitis—Azathioprine—ulcerative colitis	2.24e-05	0.00064	CcSEcCtD
Paricalcitol—Skin disorder—Hydrocortisone—ulcerative colitis	2.24e-05	0.00064	CcSEcCtD
Paricalcitol—Ill-defined disorder—Betamethasone—ulcerative colitis	2.24e-05	0.00064	CcSEcCtD
Paricalcitol—Ill-defined disorder—Dexamethasone—ulcerative colitis	2.24e-05	0.00064	CcSEcCtD
Paricalcitol—Discomfort—Triamcinolone—ulcerative colitis	2.24e-05	0.000639	CcSEcCtD
Paricalcitol—Discomfort—Methylprednisolone—ulcerative colitis	2.23e-05	0.000638	CcSEcCtD
Paricalcitol—Headache—Azathioprine—ulcerative colitis	2.23e-05	0.000637	CcSEcCtD
Paricalcitol—Hyperhidrosis—Hydrocortisone—ulcerative colitis	2.23e-05	0.000637	CcSEcCtD
Paricalcitol—Diarrhoea—Mesalazine—ulcerative colitis	2.22e-05	0.000634	CcSEcCtD
Paricalcitol—Dry mouth—Triamcinolone—ulcerative colitis	2.22e-05	0.000633	CcSEcCtD
Paricalcitol—Angioedema—Betamethasone—ulcerative colitis	2.21e-05	0.00063	CcSEcCtD
Paricalcitol—Angioedema—Dexamethasone—ulcerative colitis	2.21e-05	0.00063	CcSEcCtD
Paricalcitol—CYP24A1—Metabolism—DLD—ulcerative colitis	2.2e-05	0.00433	CbGpPWpGaD
Paricalcitol—Anorexia—Hydrocortisone—ulcerative colitis	2.2e-05	0.000628	CcSEcCtD
Paricalcitol—Angiopathy—Prednisone—ulcerative colitis	2.19e-05	0.000626	CcSEcCtD
Paricalcitol—Confusional state—Methylprednisolone—ulcerative colitis	2.19e-05	0.000624	CcSEcCtD
Paricalcitol—Immune system disorder—Prednisone—ulcerative colitis	2.18e-05	0.000623	CcSEcCtD
Paricalcitol—Malaise—Betamethasone—ulcerative colitis	2.18e-05	0.000622	CcSEcCtD
Paricalcitol—Malaise—Dexamethasone—ulcerative colitis	2.18e-05	0.000622	CcSEcCtD
Paricalcitol—Oedema—Triamcinolone—ulcerative colitis	2.17e-05	0.00062	CcSEcCtD
Paricalcitol—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—ulcerative colitis	2.17e-05	0.00427	CbGpPWpGaD
Paricalcitol—Vertigo—Betamethasone—ulcerative colitis	2.17e-05	0.000619	CcSEcCtD
Paricalcitol—Vertigo—Dexamethasone—ulcerative colitis	2.17e-05	0.000619	CcSEcCtD
Paricalcitol—Syncope—Betamethasone—ulcerative colitis	2.17e-05	0.000618	CcSEcCtD
Paricalcitol—Syncope—Dexamethasone—ulcerative colitis	2.17e-05	0.000618	CcSEcCtD
Paricalcitol—Arrhythmia—Prednisone—ulcerative colitis	2.16e-05	0.000616	CcSEcCtD
Paricalcitol—Infection—Triamcinolone—ulcerative colitis	2.16e-05	0.000616	CcSEcCtD
Paricalcitol—Hypotension—Hydrocortisone—ulcerative colitis	2.16e-05	0.000615	CcSEcCtD
Paricalcitol—Infection—Methylprednisolone—ulcerative colitis	2.15e-05	0.000615	CcSEcCtD
Paricalcitol—Dizziness—Mesalazine—ulcerative colitis	2.15e-05	0.000612	CcSEcCtD
Paricalcitol—Shock—Triamcinolone—ulcerative colitis	2.14e-05	0.00061	CcSEcCtD
Paricalcitol—Insomnia—Prednisolone—ulcerative colitis	2.14e-05	0.00061	CcSEcCtD
Paricalcitol—Alopecia—Prednisone—ulcerative colitis	2.14e-05	0.000609	CcSEcCtD
Paricalcitol—Shock—Methylprednisolone—ulcerative colitis	2.13e-05	0.000609	CcSEcCtD
Paricalcitol—Nervous system disorder—Methylprednisolone—ulcerative colitis	2.13e-05	0.000607	CcSEcCtD
Paricalcitol—Loss of consciousness—Betamethasone—ulcerative colitis	2.12e-05	0.000606	CcSEcCtD
Paricalcitol—Loss of consciousness—Dexamethasone—ulcerative colitis	2.12e-05	0.000606	CcSEcCtD
Paricalcitol—Paraesthesia—Prednisolone—ulcerative colitis	2.12e-05	0.000605	CcSEcCtD
Paricalcitol—Mental disorder—Prednisone—ulcerative colitis	2.12e-05	0.000604	CcSEcCtD
Paricalcitol—Nausea—Azathioprine—ulcerative colitis	2.12e-05	0.000604	CcSEcCtD
Paricalcitol—Skin disorder—Methylprednisolone—ulcerative colitis	2.11e-05	0.000601	CcSEcCtD
Paricalcitol—Malnutrition—Prednisone—ulcerative colitis	2.1e-05	0.0006	CcSEcCtD
Paricalcitol—Musculoskeletal discomfort—Hydrocortisone—ulcerative colitis	2.1e-05	0.0006	CcSEcCtD
Paricalcitol—Hyperhidrosis—Triamcinolone—ulcerative colitis	2.1e-05	0.000599	CcSEcCtD
Paricalcitol—Hyperhidrosis—Methylprednisolone—ulcerative colitis	2.1e-05	0.000598	CcSEcCtD
Paricalcitol—Insomnia—Hydrocortisone—ulcerative colitis	2.09e-05	0.000596	CcSEcCtD
Paricalcitol—Hypertension—Betamethasone—ulcerative colitis	2.09e-05	0.000595	CcSEcCtD
Paricalcitol—Hypertension—Dexamethasone—ulcerative colitis	2.09e-05	0.000595	CcSEcCtD
Paricalcitol—Paraesthesia—Hydrocortisone—ulcerative colitis	2.07e-05	0.000591	CcSEcCtD
Paricalcitol—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—ulcerative colitis	2.07e-05	0.00407	CbGpPWpGaD
Paricalcitol—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—ulcerative colitis	2.07e-05	0.00406	CbGpPWpGaD
Paricalcitol—Vomiting—Mesalazine—ulcerative colitis	2.06e-05	0.000589	CcSEcCtD
Paricalcitol—Myalgia—Dexamethasone—ulcerative colitis	2.06e-05	0.000587	CcSEcCtD
Paricalcitol—Myalgia—Betamethasone—ulcerative colitis	2.06e-05	0.000587	CcSEcCtD
Paricalcitol—Anxiety—Betamethasone—ulcerative colitis	2.05e-05	0.000585	CcSEcCtD
Paricalcitol—Anxiety—Dexamethasone—ulcerative colitis	2.05e-05	0.000585	CcSEcCtD
Paricalcitol—Rash—Mesalazine—ulcerative colitis	2.05e-05	0.000584	CcSEcCtD
Paricalcitol—Dermatitis—Mesalazine—ulcerative colitis	2.04e-05	0.000583	CcSEcCtD
Paricalcitol—UGT1A4—Metabolism—CHP1—ulcerative colitis	2.04e-05	0.00401	CbGpPWpGaD
Paricalcitol—Headache—Mesalazine—ulcerative colitis	2.03e-05	0.00058	CcSEcCtD
Paricalcitol—Discomfort—Dexamethasone—ulcerative colitis	2.03e-05	0.00058	CcSEcCtD
Paricalcitol—Discomfort—Betamethasone—ulcerative colitis	2.03e-05	0.00058	CcSEcCtD
Paricalcitol—Dyspepsia—Hydrocortisone—ulcerative colitis	2.03e-05	0.00058	CcSEcCtD
Paricalcitol—Hypotension—Methylprednisolone—ulcerative colitis	2.03e-05	0.000578	CcSEcCtD
Paricalcitol—Pain—Prednisolone—ulcerative colitis	2.02e-05	0.000577	CcSEcCtD
Paricalcitol—Decreased appetite—Hydrocortisone—ulcerative colitis	2.01e-05	0.000572	CcSEcCtD
Paricalcitol—Gastrointestinal disorder—Hydrocortisone—ulcerative colitis	1.99e-05	0.000568	CcSEcCtD
Paricalcitol—Fatigue—Hydrocortisone—ulcerative colitis	1.99e-05	0.000568	CcSEcCtD
Paricalcitol—Musculoskeletal discomfort—Triamcinolone—ulcerative colitis	1.98e-05	0.000565	CcSEcCtD
Paricalcitol—Musculoskeletal discomfort—Methylprednisolone—ulcerative colitis	1.98e-05	0.000564	CcSEcCtD
Paricalcitol—Pain—Hydrocortisone—ulcerative colitis	1.97e-05	0.000563	CcSEcCtD
Paricalcitol—Oedema—Dexamethasone—ulcerative colitis	1.97e-05	0.000563	CcSEcCtD
Paricalcitol—Oedema—Betamethasone—ulcerative colitis	1.97e-05	0.000563	CcSEcCtD
Paricalcitol—Insomnia—Triamcinolone—ulcerative colitis	1.97e-05	0.000561	CcSEcCtD
Paricalcitol—Insomnia—Methylprednisolone—ulcerative colitis	1.96e-05	0.00056	CcSEcCtD
Paricalcitol—Infection—Betamethasone—ulcerative colitis	1.96e-05	0.000559	CcSEcCtD
Paricalcitol—Infection—Dexamethasone—ulcerative colitis	1.96e-05	0.000559	CcSEcCtD
Paricalcitol—Ill-defined disorder—Prednisone—ulcerative colitis	1.95e-05	0.000557	CcSEcCtD
Paricalcitol—Paraesthesia—Triamcinolone—ulcerative colitis	1.95e-05	0.000557	CcSEcCtD
Paricalcitol—Feeling abnormal—Prednisolone—ulcerative colitis	1.95e-05	0.000556	CcSEcCtD
Paricalcitol—Paraesthesia—Methylprednisolone—ulcerative colitis	1.95e-05	0.000556	CcSEcCtD
Paricalcitol—Anaemia—Prednisone—ulcerative colitis	1.94e-05	0.000555	CcSEcCtD
Paricalcitol—Shock—Betamethasone—ulcerative colitis	1.94e-05	0.000553	CcSEcCtD
Paricalcitol—Shock—Dexamethasone—ulcerative colitis	1.94e-05	0.000553	CcSEcCtD
Paricalcitol—Dyspnoea—Triamcinolone—ulcerative colitis	1.94e-05	0.000553	CcSEcCtD
Paricalcitol—Nervous system disorder—Betamethasone—ulcerative colitis	1.93e-05	0.000552	CcSEcCtD
Paricalcitol—Nervous system disorder—Dexamethasone—ulcerative colitis	1.93e-05	0.000552	CcSEcCtD
Paricalcitol—Agitation—Prednisone—ulcerative colitis	1.93e-05	0.000552	CcSEcCtD
Paricalcitol—Nausea—Mesalazine—ulcerative colitis	1.93e-05	0.00055	CcSEcCtD
Paricalcitol—Angioedema—Prednisone—ulcerative colitis	1.92e-05	0.000549	CcSEcCtD
Paricalcitol—Dyspepsia—Triamcinolone—ulcerative colitis	1.91e-05	0.000546	CcSEcCtD
Paricalcitol—Dyspepsia—Methylprednisolone—ulcerative colitis	1.91e-05	0.000545	CcSEcCtD
Paricalcitol—Hyperhidrosis—Betamethasone—ulcerative colitis	1.91e-05	0.000544	CcSEcCtD
Paricalcitol—Hyperhidrosis—Dexamethasone—ulcerative colitis	1.91e-05	0.000544	CcSEcCtD
Paricalcitol—Feeling abnormal—Hydrocortisone—ulcerative colitis	1.9e-05	0.000543	CcSEcCtD
Paricalcitol—Malaise—Prednisone—ulcerative colitis	1.9e-05	0.000541	CcSEcCtD
Paricalcitol—Vertigo—Prednisone—ulcerative colitis	1.89e-05	0.000539	CcSEcCtD
Paricalcitol—Gastrointestinal pain—Hydrocortisone—ulcerative colitis	1.89e-05	0.000538	CcSEcCtD
Paricalcitol—Syncope—Prednisone—ulcerative colitis	1.89e-05	0.000538	CcSEcCtD
Paricalcitol—Anorexia—Betamethasone—ulcerative colitis	1.88e-05	0.000536	CcSEcCtD
Paricalcitol—Anorexia—Dexamethasone—ulcerative colitis	1.88e-05	0.000536	CcSEcCtD
Paricalcitol—Urticaria—Prednisolone—ulcerative colitis	1.88e-05	0.000536	CcSEcCtD
Paricalcitol—Fatigue—Triamcinolone—ulcerative colitis	1.87e-05	0.000535	CcSEcCtD
Paricalcitol—Fatigue—Methylprednisolone—ulcerative colitis	1.87e-05	0.000533	CcSEcCtD
Paricalcitol—Pain—Triamcinolone—ulcerative colitis	1.86e-05	0.00053	CcSEcCtD
Paricalcitol—Loss of consciousness—Prednisone—ulcerative colitis	1.85e-05	0.000528	CcSEcCtD
Paricalcitol—Hypotension—Dexamethasone—ulcerative colitis	1.84e-05	0.000526	CcSEcCtD
Paricalcitol—Hypotension—Betamethasone—ulcerative colitis	1.84e-05	0.000526	CcSEcCtD
Paricalcitol—Urticaria—Hydrocortisone—ulcerative colitis	1.83e-05	0.000523	CcSEcCtD
Paricalcitol—Abdominal pain—Hydrocortisone—ulcerative colitis	1.82e-05	0.000521	CcSEcCtD
Paricalcitol—Body temperature increased—Hydrocortisone—ulcerative colitis	1.82e-05	0.000521	CcSEcCtD
Paricalcitol—Hypertension—Prednisone—ulcerative colitis	1.82e-05	0.000518	CcSEcCtD
Paricalcitol—Musculoskeletal discomfort—Betamethasone—ulcerative colitis	1.8e-05	0.000513	CcSEcCtD
Paricalcitol—Musculoskeletal discomfort—Dexamethasone—ulcerative colitis	1.8e-05	0.000513	CcSEcCtD
Paricalcitol—Myalgia—Prednisone—ulcerative colitis	1.79e-05	0.000511	CcSEcCtD
Paricalcitol—Arthralgia—Prednisone—ulcerative colitis	1.79e-05	0.000511	CcSEcCtD
Paricalcitol—Feeling abnormal—Triamcinolone—ulcerative colitis	1.79e-05	0.000511	CcSEcCtD
Paricalcitol—Feeling abnormal—Methylprednisolone—ulcerative colitis	1.79e-05	0.00051	CcSEcCtD
Paricalcitol—Anxiety—Prednisone—ulcerative colitis	1.78e-05	0.000509	CcSEcCtD
Paricalcitol—Insomnia—Dexamethasone—ulcerative colitis	1.78e-05	0.000509	CcSEcCtD
Paricalcitol—Insomnia—Betamethasone—ulcerative colitis	1.78e-05	0.000509	CcSEcCtD
Paricalcitol—Unspecified disorder of skin and subcutaneous tissue—Prednisone—ulcerative colitis	1.78e-05	0.000508	CcSEcCtD
Paricalcitol—Gastrointestinal pain—Methylprednisolone—ulcerative colitis	1.77e-05	0.000506	CcSEcCtD
Paricalcitol—Paraesthesia—Betamethasone—ulcerative colitis	1.77e-05	0.000505	CcSEcCtD
Paricalcitol—Paraesthesia—Dexamethasone—ulcerative colitis	1.77e-05	0.000505	CcSEcCtD
Paricalcitol—Discomfort—Prednisone—ulcerative colitis	1.77e-05	0.000505	CcSEcCtD
Paricalcitol—UGT1A4—Metabolism—DLD—ulcerative colitis	1.76e-05	0.00346	CbGpPWpGaD
Paricalcitol—Hypersensitivity—Prednisolone—ulcerative colitis	1.74e-05	0.000497	CcSEcCtD
Paricalcitol—Dyspepsia—Dexamethasone—ulcerative colitis	1.74e-05	0.000495	CcSEcCtD
Paricalcitol—Dyspepsia—Betamethasone—ulcerative colitis	1.74e-05	0.000495	CcSEcCtD
Paricalcitol—Urticaria—Triamcinolone—ulcerative colitis	1.73e-05	0.000493	CcSEcCtD
Paricalcitol—Urticaria—Methylprednisolone—ulcerative colitis	1.72e-05	0.000491	CcSEcCtD
Paricalcitol—Body temperature increased—Triamcinolone—ulcerative colitis	1.72e-05	0.00049	CcSEcCtD
Paricalcitol—Oedema—Prednisone—ulcerative colitis	1.72e-05	0.00049	CcSEcCtD
Paricalcitol—Abdominal pain—Methylprednisolone—ulcerative colitis	1.71e-05	0.000489	CcSEcCtD
Paricalcitol—Decreased appetite—Betamethasone—ulcerative colitis	1.71e-05	0.000489	CcSEcCtD
Paricalcitol—Decreased appetite—Dexamethasone—ulcerative colitis	1.71e-05	0.000489	CcSEcCtD
Paricalcitol—Infection—Prednisone—ulcerative colitis	1.71e-05	0.000487	CcSEcCtD
Paricalcitol—Gastrointestinal disorder—Dexamethasone—ulcerative colitis	1.7e-05	0.000486	CcSEcCtD
Paricalcitol—Gastrointestinal disorder—Betamethasone—ulcerative colitis	1.7e-05	0.000486	CcSEcCtD
Paricalcitol—Hypersensitivity—Hydrocortisone—ulcerative colitis	1.7e-05	0.000485	CcSEcCtD
Paricalcitol—Fatigue—Dexamethasone—ulcerative colitis	1.7e-05	0.000485	CcSEcCtD
Paricalcitol—Fatigue—Betamethasone—ulcerative colitis	1.7e-05	0.000485	CcSEcCtD
Paricalcitol—Shock—Prednisone—ulcerative colitis	1.69e-05	0.000482	CcSEcCtD
Paricalcitol—Pain—Betamethasone—ulcerative colitis	1.69e-05	0.000481	CcSEcCtD
Paricalcitol—Pain—Dexamethasone—ulcerative colitis	1.69e-05	0.000481	CcSEcCtD
Paricalcitol—Nervous system disorder—Prednisone—ulcerative colitis	1.68e-05	0.00048	CcSEcCtD
Paricalcitol—Skin disorder—Prednisone—ulcerative colitis	1.67e-05	0.000476	CcSEcCtD
Paricalcitol—Hyperhidrosis—Prednisone—ulcerative colitis	1.66e-05	0.000474	CcSEcCtD
Paricalcitol—Asthenia—Hydrocortisone—ulcerative colitis	1.66e-05	0.000472	CcSEcCtD
Paricalcitol—Anorexia—Prednisone—ulcerative colitis	1.64e-05	0.000467	CcSEcCtD
Paricalcitol—Pruritus—Hydrocortisone—ulcerative colitis	1.63e-05	0.000466	CcSEcCtD
Paricalcitol—Feeling abnormal—Dexamethasone—ulcerative colitis	1.62e-05	0.000464	CcSEcCtD
Paricalcitol—Feeling abnormal—Betamethasone—ulcerative colitis	1.62e-05	0.000464	CcSEcCtD
Paricalcitol—Gastrointestinal pain—Betamethasone—ulcerative colitis	1.61e-05	0.00046	CcSEcCtD
Paricalcitol—Gastrointestinal pain—Dexamethasone—ulcerative colitis	1.61e-05	0.00046	CcSEcCtD
Paricalcitol—Hypersensitivity—Triamcinolone—ulcerative colitis	1.6e-05	0.000457	CcSEcCtD
Paricalcitol—Hypersensitivity—Methylprednisolone—ulcerative colitis	1.6e-05	0.000456	CcSEcCtD
Paricalcitol—Diarrhoea—Hydrocortisone—ulcerative colitis	1.58e-05	0.000451	CcSEcCtD
Paricalcitol—UGT1A4—NRF2 pathway—TGFB1—ulcerative colitis	1.57e-05	0.00309	CbGpPWpGaD
Paricalcitol—Urticaria—Betamethasone—ulcerative colitis	1.57e-05	0.000447	CcSEcCtD
Paricalcitol—Urticaria—Dexamethasone—ulcerative colitis	1.57e-05	0.000447	CcSEcCtD
Paricalcitol—Musculoskeletal discomfort—Prednisone—ulcerative colitis	1.56e-05	0.000446	CcSEcCtD
Paricalcitol—Dizziness—Prednisolone—ulcerative colitis	1.56e-05	0.000446	CcSEcCtD
Paricalcitol—Asthenia—Triamcinolone—ulcerative colitis	1.56e-05	0.000445	CcSEcCtD
Paricalcitol—Body temperature increased—Dexamethasone—ulcerative colitis	1.56e-05	0.000445	CcSEcCtD
Paricalcitol—Abdominal pain—Dexamethasone—ulcerative colitis	1.56e-05	0.000445	CcSEcCtD
Paricalcitol—Abdominal pain—Betamethasone—ulcerative colitis	1.56e-05	0.000445	CcSEcCtD
Paricalcitol—Body temperature increased—Betamethasone—ulcerative colitis	1.56e-05	0.000445	CcSEcCtD
Paricalcitol—Asthenia—Methylprednisolone—ulcerative colitis	1.56e-05	0.000444	CcSEcCtD
Paricalcitol—Insomnia—Prednisone—ulcerative colitis	1.55e-05	0.000443	CcSEcCtD
Paricalcitol—Paraesthesia—Prednisone—ulcerative colitis	1.54e-05	0.00044	CcSEcCtD
Paricalcitol—Pruritus—Triamcinolone—ulcerative colitis	1.54e-05	0.000439	CcSEcCtD
Paricalcitol—Pruritus—Methylprednisolone—ulcerative colitis	1.53e-05	0.000438	CcSEcCtD
Paricalcitol—Dizziness—Hydrocortisone—ulcerative colitis	1.53e-05	0.000435	CcSEcCtD
Paricalcitol—CYP3A4—Phase 1 - Functionalization of compounds—PTGS1—ulcerative colitis	1.52e-05	0.00299	CbGpPWpGaD
Paricalcitol—Dyspepsia—Prednisone—ulcerative colitis	1.51e-05	0.000431	CcSEcCtD
Paricalcitol—Decreased appetite—Prednisone—ulcerative colitis	1.49e-05	0.000426	CcSEcCtD
Paricalcitol—Rash—Prednisolone—ulcerative colitis	1.49e-05	0.000425	CcSEcCtD
Paricalcitol—Dermatitis—Prednisolone—ulcerative colitis	1.49e-05	0.000425	CcSEcCtD
Paricalcitol—Diarrhoea—Methylprednisolone—ulcerative colitis	1.48e-05	0.000423	CcSEcCtD
Paricalcitol—Fatigue—Prednisone—ulcerative colitis	1.48e-05	0.000422	CcSEcCtD
Paricalcitol—Headache—Prednisolone—ulcerative colitis	1.48e-05	0.000422	CcSEcCtD
Paricalcitol—Constipation—Prednisone—ulcerative colitis	1.47e-05	0.000419	CcSEcCtD
Paricalcitol—Vomiting—Hydrocortisone—ulcerative colitis	1.47e-05	0.000419	CcSEcCtD
Paricalcitol—Rash—Hydrocortisone—ulcerative colitis	1.46e-05	0.000415	CcSEcCtD
Paricalcitol—Dermatitis—Hydrocortisone—ulcerative colitis	1.45e-05	0.000415	CcSEcCtD
Paricalcitol—Headache—Hydrocortisone—ulcerative colitis	1.45e-05	0.000413	CcSEcCtD
Paricalcitol—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—ulcerative colitis	1.44e-05	0.00283	CbGpPWpGaD
Paricalcitol—Dizziness—Triamcinolone—ulcerative colitis	1.44e-05	0.00041	CcSEcCtD
Paricalcitol—Dizziness—Methylprednisolone—ulcerative colitis	1.43e-05	0.000409	CcSEcCtD
Paricalcitol—Feeling abnormal—Prednisone—ulcerative colitis	1.41e-05	0.000404	CcSEcCtD
Paricalcitol—Asthenia—Betamethasone—ulcerative colitis	1.41e-05	0.000404	CcSEcCtD
Paricalcitol—Asthenia—Dexamethasone—ulcerative colitis	1.41e-05	0.000404	CcSEcCtD
Paricalcitol—Gastrointestinal pain—Prednisone—ulcerative colitis	1.4e-05	0.000401	CcSEcCtD
Paricalcitol—Nausea—Prednisolone—ulcerative colitis	1.4e-05	0.0004	CcSEcCtD
Paricalcitol—VDR—Direct p53 effectors—TP53—ulcerative colitis	1.4e-05	0.00276	CbGpPWpGaD
Paricalcitol—Pruritus—Dexamethasone—ulcerative colitis	1.39e-05	0.000398	CcSEcCtD
Paricalcitol—Pruritus—Betamethasone—ulcerative colitis	1.39e-05	0.000398	CcSEcCtD
Paricalcitol—Vomiting—Triamcinolone—ulcerative colitis	1.38e-05	0.000394	CcSEcCtD
Paricalcitol—Vomiting—Methylprednisolone—ulcerative colitis	1.38e-05	0.000393	CcSEcCtD
Paricalcitol—Nausea—Hydrocortisone—ulcerative colitis	1.37e-05	0.000391	CcSEcCtD
Paricalcitol—Rash—Triamcinolone—ulcerative colitis	1.37e-05	0.000391	CcSEcCtD
Paricalcitol—Dermatitis—Triamcinolone—ulcerative colitis	1.37e-05	0.000391	CcSEcCtD
Paricalcitol—Rash—Methylprednisolone—ulcerative colitis	1.37e-05	0.00039	CcSEcCtD
Paricalcitol—Dermatitis—Methylprednisolone—ulcerative colitis	1.37e-05	0.00039	CcSEcCtD
Paricalcitol—Urticaria—Prednisone—ulcerative colitis	1.36e-05	0.000389	CcSEcCtD
Paricalcitol—Headache—Triamcinolone—ulcerative colitis	1.36e-05	0.000388	CcSEcCtD
Paricalcitol—Headache—Methylprednisolone—ulcerative colitis	1.36e-05	0.000388	CcSEcCtD
Paricalcitol—Body temperature increased—Prednisone—ulcerative colitis	1.36e-05	0.000387	CcSEcCtD
Paricalcitol—Abdominal pain—Prednisone—ulcerative colitis	1.36e-05	0.000387	CcSEcCtD
Paricalcitol—Diarrhoea—Dexamethasone—ulcerative colitis	1.35e-05	0.000385	CcSEcCtD
Paricalcitol—Diarrhoea—Betamethasone—ulcerative colitis	1.35e-05	0.000385	CcSEcCtD
Paricalcitol—Dizziness—Dexamethasone—ulcerative colitis	1.3e-05	0.000372	CcSEcCtD
Paricalcitol—Dizziness—Betamethasone—ulcerative colitis	1.3e-05	0.000372	CcSEcCtD
Paricalcitol—Nausea—Triamcinolone—ulcerative colitis	1.29e-05	0.000368	CcSEcCtD
Paricalcitol—Nausea—Methylprednisolone—ulcerative colitis	1.29e-05	0.000367	CcSEcCtD
Paricalcitol—VDR—Gene Expression—HNF4A—ulcerative colitis	1.29e-05	0.00253	CbGpPWpGaD
Paricalcitol—Hypersensitivity—Prednisone—ulcerative colitis	1.26e-05	0.000361	CcSEcCtD
Paricalcitol—VDR—Gene Expression—MAML2—ulcerative colitis	1.25e-05	0.00247	CbGpPWpGaD
Paricalcitol—Vomiting—Dexamethasone—ulcerative colitis	1.25e-05	0.000358	CcSEcCtD
Paricalcitol—Vomiting—Betamethasone—ulcerative colitis	1.25e-05	0.000358	CcSEcCtD
Paricalcitol—Rash—Dexamethasone—ulcerative colitis	1.24e-05	0.000355	CcSEcCtD
Paricalcitol—Rash—Betamethasone—ulcerative colitis	1.24e-05	0.000355	CcSEcCtD
Paricalcitol—Dermatitis—Dexamethasone—ulcerative colitis	1.24e-05	0.000354	CcSEcCtD
Paricalcitol—Dermatitis—Betamethasone—ulcerative colitis	1.24e-05	0.000354	CcSEcCtD
Paricalcitol—Headache—Dexamethasone—ulcerative colitis	1.24e-05	0.000352	CcSEcCtD
Paricalcitol—Headache—Betamethasone—ulcerative colitis	1.24e-05	0.000352	CcSEcCtD
Paricalcitol—Asthenia—Prednisone—ulcerative colitis	1.23e-05	0.000352	CcSEcCtD
Paricalcitol—Pruritus—Prednisone—ulcerative colitis	1.21e-05	0.000347	CcSEcCtD
Paricalcitol—Diarrhoea—Prednisone—ulcerative colitis	1.17e-05	0.000335	CcSEcCtD
Paricalcitol—Nausea—Betamethasone—ulcerative colitis	1.17e-05	0.000334	CcSEcCtD
Paricalcitol—Nausea—Dexamethasone—ulcerative colitis	1.17e-05	0.000334	CcSEcCtD
Paricalcitol—CYP24A1—Metabolism of lipids and lipoproteins—PPARG—ulcerative colitis	1.16e-05	0.00229	CbGpPWpGaD
Paricalcitol—VDR—Generic Transcription Pathway—PPARG—ulcerative colitis	1.16e-05	0.00228	CbGpPWpGaD
Paricalcitol—Dizziness—Prednisone—ulcerative colitis	1.14e-05	0.000324	CcSEcCtD
Paricalcitol—Vomiting—Prednisone—ulcerative colitis	1.09e-05	0.000312	CcSEcCtD
Paricalcitol—Rash—Prednisone—ulcerative colitis	1.08e-05	0.000309	CcSEcCtD
Paricalcitol—Dermatitis—Prednisone—ulcerative colitis	1.08e-05	0.000309	CcSEcCtD
Paricalcitol—Headache—Prednisone—ulcerative colitis	1.08e-05	0.000307	CcSEcCtD
Paricalcitol—CYP24A1—Metabolism—PTGS1—ulcerative colitis	1.06e-05	0.00209	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism of lipids and lipoproteins—ALB—ulcerative colitis	1.05e-05	0.00206	CbGpPWpGaD
Paricalcitol—Nausea—Prednisone—ulcerative colitis	1.02e-05	0.000291	CcSEcCtD
Paricalcitol—CYP24A1—Metabolism—CALM3—ulcerative colitis	9.59e-06	0.00188	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism of lipids and lipoproteins—PTGS2—ulcerative colitis	9.16e-06	0.0018	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—PTGS1—ulcerative colitis	8.51e-06	0.00167	CbGpPWpGaD
Paricalcitol—CYP3A4—Biological oxidations—PTGS1—ulcerative colitis	8.08e-06	0.00159	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—CALM3—ulcerative colitis	7.67e-06	0.00151	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—ABCB1—ulcerative colitis	7.46e-06	0.00147	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—ADCY5—ulcerative colitis	6.96e-06	0.00137	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—ABCB1—ulcerative colitis	5.96e-06	0.00117	CbGpPWpGaD
Paricalcitol—VDR—Gene Expression—PPARG—ulcerative colitis	5.59e-06	0.0011	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—ADCY5—ulcerative colitis	5.56e-06	0.00109	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—PPARG—ulcerative colitis	5.19e-06	0.00102	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—ALB—ulcerative colitis	4.66e-06	0.000917	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—PPARG—ulcerative colitis	4.15e-06	0.000815	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—PTGS2—ulcerative colitis	4.08e-06	0.000802	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—ALB—ulcerative colitis	3.73e-06	0.000733	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—CHP1—ulcerative colitis	3.31e-06	0.000651	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—PTGS2—ulcerative colitis	3.26e-06	0.000641	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—DLD—ulcerative colitis	2.86e-06	0.000562	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—PTGS1—ulcerative colitis	1.38e-06	0.000272	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—CALM3—ulcerative colitis	1.24e-06	0.000245	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—ABCB1—ulcerative colitis	9.68e-07	0.00019	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—ADCY5—ulcerative colitis	9.03e-07	0.000177	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—PPARG—ulcerative colitis	6.73e-07	0.000132	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—ALB—ulcerative colitis	6.05e-07	0.000119	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—PTGS2—ulcerative colitis	5.3e-07	0.000104	CbGpPWpGaD
